The Uniformed Services University of the Health Sciences (USU) is the Nation's federal health sciences university and is committed to excellence in military medicine and public health during peace and war. We provide the Nation with health professionals dedicated to career service in the Department of Defense and the United States Public Health Service and with scientists who serve the common good. We serve the uniformed services and the Nation as an outstanding academic health sciences center with a worldwide perspective for education, research, service, and consultation; we are unique in relating these activities to military medicine, disaster medicine, and military medical readiness. USU is located in Bethesda, MD on the grounds of the Naval Support Activity Bethesda.

USU intends to negotiate on a sole source basis with Research and Diagnostic Systems, Inc. (R&D), located in Minneapolis, MN for the following:

• Mouse G-CSF Antibody - 12.5 mg
• Mouse IL-6 Antibody - 12.5 mg
• Isotype Control Antibody - 12.5 mg

These antibodies will be procured in accordance with the procedures of FAR Part 12-Commercial Items and FAR Part 13-Simplified Acquisition Procedures.

Sole source determination is made in accordance with:

FAR Part 13.106-1 Soliciting Competition

(b) Soliciting from a single source
(1) For purchases not exceeding the simplified
acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available.

The requested antibodies will be used in a protocol entitled: Preclinical development of a bridging therapy for radiation injury using tocopherol succinate in mice. R&D is the manufacturer of the requested antibodies. Past studies in mice have been done using antibodies from R&D, making it essential to continue utilizing them as the supplier. Endotoxin testing has already been completed with their formulations, making it ready to use upon arrival. Their antibody formulations do not contain azide or other preservatives, which is critical as it will be injected into animals.

R&D is the only reasonable known source that can provide the requested antibodies.

This is not a request for quotes and a solicitation package will not be issued. Sources interested in responding to this requirement must be able to provide compelling evidence that they can provide the abovementioned requirement as specified. A determination by the government not to compete this proposed contractual action based upon responses received is solely within the discretion of the government. Responses must be received via email ([email protected]) by 10:00 p.m. EST on June 26, 2013.

Bid Protests Not Available